- Home
- Insider Trading Stock Activity
- Smith Jeffrey T L
Stock Insider Trading Activity of Smith Jeffrey T L
Smith Jeffrey T L
Sell
EVP & Chief Medical Officer
ZYME Jan 12, 2026
Avg Cost/Share
$22.67
Shares
9,310
Total Value
$211,090.29
Owned After
26,708
SEC Form 4
Smith Jeffrey T L
Sell
EVP & Chief Medical Officer
ZYME Jan 5, 2026
Avg Cost/Share
$25.10
Shares
10,538
Total Value
$264,471.13
Owned After
26,708
SEC Form 4
Smith Jeffrey T L
Sell
EVP & Chief Medical Officer
ZYME Jan 6, 2025
Avg Cost/Share
$14.92
Shares
11,110
Total Value
$165,806.75
Owned After
26,708
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Smith Jeffrey T L | ZYME | EVP & Chief Medical Officer | Jan 12, 2026 | Sell | $22.67 | 9,310 | $211,090.29 | 26,708 | |
| Smith Jeffrey T L | ZYME | EVP & Chief Medical Officer | Jan 5, 2026 | Sell | $25.10 | 10,538 | $264,471.13 | 26,708 | |
| Smith Jeffrey T L | ZYME | EVP & Chief Medical Officer | Jan 6, 2025 | Sell | $14.92 | 11,110 | $165,806.75 | 26,708 |